Benjamin Weide

TL;DR: Discontinuation of BRAFi therapy after a CR has to be balanced carefully with the potential risk of nonresponding to BRAFi retreatment in the case of relapse.

TL;DR: Survival of patients with LNM in MUP and with secondary LNM is similar and considerably more favourable compared to those with primary LNM.

TL;DR: In high-risk patients (stages IIB to III), an initial staging examination with CT is recommended, and regular follow-up every 6 months with whole body imaging by CT or magnetic resonance imaging seems useful.

TL;DR: This combined immunotherapy is associated with adverse events similar to those associated with the respective monotherapies, however, this study does not provide any evidence of improved efficacy of the combination over ipilimumab alone.

TL;DR: Correlations of cell differentiation status with survival revealed a negative association of early‐differentiated Vδ1+ T cells with survival, both on the basis of relative frequencies and absolute counts, and these findings suggest peripheral blood frequencies of V Greek T‐cells as a potential prognostic marker in melanoma.